세계의 뇌 모니터링 시장 : 제품별, 적응증별, 모달리티별, 병리학별, 최종 사용자별, 지역별 예측(-2028년)
Brain Monitoring Market by Devices Accessories, Modality, Indication, End User - Global Forecast to 2028
상품코드:1419618
리서치사:MarketsandMarkets
발행일:2024년 01월
페이지 정보:영문 336 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
조사 범위
조사 대상연도
2021년-2028년
기준연도
2022년
예측 기간
2023년-2028년
검토 단위
금액(10억 달러)
부문
제품별, 적응증별, 모달리티별, 병상별, 최종 사용자별, 지역별
대상 지역
북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카
세계의 뇌 모니터링(Brain Monitoring) 시장 규모는 2023년 35억 달러에서 2028년 48억 달러에 달할 것으로 추정되며, CAGR 6.3%로 추이하며 성장 할 것으로 예상됩니다.
뇌 모니터링 시장은 주로 신경질환 증가, 신경퇴행성 질환에 대한 의식 증가, 외상성 뇌손상의 급증, 임상시험에서 뇌 모니터링의 이용 확대에 의해 추진력을 얻고 있습니다. 게다가 비침습성·최소 침습성 디바이스에 대한 수요 증가, 뇌 모니터링 툴의 치료 용도의 확대, 신흥국에서의 의료 섹터의 급성장 등이 이 시장의 촉진 요인이 될 것으로 보입니다. 반대로 복잡한 뇌 모니터링 절차와 장치에 따른 고액의 비용, 불리한 상환 정책, 뇌 모니터링 장치를 효과적으로 조작할 수 있는 숙련된 전문가의 부족 등 과제가 시장 성장을 방해하고 있습니다.
제품별로 디바이스 부문은 2022년 뇌 모니터링 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이것은 주로 조기 진단의 필요성, 가정용으로 설계된 혁신적인 휴대용 및 웨어러블 모니터링 장치의 존재, 환자 의식 증가와 함께 신경학적 질환, 신경 퇴행성 질환, 정신병 성 질환, 수면장애 발생이 증가하고 있기 때문입니다.
전극 분야는 예측 기간 동안 가장 높은 성장률을 나타낼 것으로 예상됩니다. 기술의 진보로 전극과 조직의 인터페이스가 개선되어 이 시장에서 비용 효율적이고 고기능 전극을 만들 수 있습니다. 게다가, 일회용 전극의 통합은 그 수용성과 이 시장 부문의 확대를 크게 뒷받침하고 있습니다.
모달리티별로 보면, 2022년의 뇌 모니터링 시장에서는 고정형 디바이스가 최대의 점유율을 차지하고 있습니다. 병원, 전문 의료 센터, 조사 기관과 같은 임상 환경에서의 사용이 확립되어 있기 때문에 이러한 고정 장비는 일반적으로 종합적인 뇌 모니터링 벤치마킹으로 간주됩니다. 그 명성은 정확성, 신뢰성 및 정교한 기능에서 비롯됩니다.
세계의 뇌 모니터링(Brain Monitoring) 시장에 대해 조사했으며, 제품별·적응증별·모달리티별·병리학별·최종 사용자별·지역별 동향/시장 진출기업 개요 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
소개
시장 역학
업계 동향
가격 분석
밸류체인 분석
생태계 시장/지도
Porter's Five Forces 분석
관세 및 규제 분석
기술 분석
특허 분석
무역 분석
사례 연구 분석
주요 회의 및 이벤트(2023-2024년)
주요 이해관계자와 구매 기준
미충족 요구 분석과 최종 사용자의 기대
고객의 비즈니스에 영향을 미치는 동향/혼란
상환 시나리오 분석
비즈니스 모델 분석
투자와 자금조달 시나리오
제6장 뇌 모니터링 시장, 제품별
소개
디바이스
액세서리
제7장 뇌 모니터링 시장, 적응증별
소개
비침습적 치료
침습적 치료
제8장 뇌 모니터링 시장, 모달리티별
소개
고정 디바이스
휴대용 장치
웨어러블 디바이스
제9장 뇌 모니터링 시장, 병리학별
소개
외상성 뇌 손상
뇌졸중
치매
두통 장애
수면장애
파킨슨병
간질
헌팅턴병
기타
제10장 뇌 모니터링 시장, 최종 사용자별
소개
병원
신경센터
진단센터
외래수술센터(ASC) 및 클리닉
기타
제11장 뇌 모니터링 시장, 지역별
소개
북미
유럽
아시아 태평양
남미
중동 및 아프리카
제12장 경쟁 구도
소개
주요 전략/유력 기업
수익 점유율 분석
시장 점유율 분석
기업 평가 매트릭스
스타트업/중소기업 평가 매트릭스
경쟁 시나리오
제13장 기업 개요
주요 진출기업
NATUS MEDICAL INCORPORATED
NIHON KOHDEN CORPORATION
PHILIPS HEALTHCARE
GE HEALTHCARE
SIEMENS HEALTHINEERS AG
COMPUMEDICS LIMITED
MEDTRONIC
EDWARDS LIFESCIENCES CORPORATION
ADVANCED BRAIN MONITORING, INC.
CADWELL INDUSTRIES, INC.
NEUROWAVE SYSTEMS, INC.
NEUROSOFT
CGX
NONIN
RIMED
EMOTIV
DRAGERWERK AG&CO. KGAA
MASIMO CORPORATION
LUCIOLE MEDICAL AG
INTEGRA LIFESCIENCES
기타 기업
INFRASCAN, INC.
NEUSOFT MEDICAL SYSTEMS CO., LTD.
NORAXON USA
STERNMED GMBH
CERIBELL
제14장 부록
LYJ
영문 목차
영문목차
Report Description
Scope of the Report
Years Considered for the Study
2021-2028
Base Year
2022
Forecast Period
2023-2028
Units Considered
Value (USD) Billion
Segments
Product, Proceudre, Modality, Medical Condition, End User, and Region
Regions covered
North America, Europe, APAC, Latin America, and Middle East Africa
The global brain monitoring market size is estimated to be USD 4.8 billion by 2028, from USD 3.5 billion in 2023, at a CAGR of 6.3%. The brain monitoring market experiences propulsion primarily due to heightened occurrences of neurological disorders, increased awareness regarding neurodegenerative diseases, a surge in traumatic brain injuries, and amplified utilization of brain monitoring in clinical trials. Moreover, the market is set to benefit from escalating demands for non-invasive and minimally invasive devices, the expanding spectrum of therapeutic applications for brain monitoring tools, and the burgeoning healthcare sector in emerging economies. Conversely, challenges such as the high expenses associated with complex brain monitoring procedures and devices, unfavorable reimbursement policies, and a shortage of proficient professionals capable of effectively operating brain monitoring devices impede the market's growth.
"The devices segment is expected to account for the largest brain monitoring devices market share in 2022."
By product, the global brain monitoring market is categorized into devices and accessories. The devices segment is expected to hold the largest share of the brain monitoring market in 2022. This is primarily attributed to the increasing occurrence of neurological, neurodegenerative, psychotic, and sleep disorders, alongside the imperative for early diagnosis, the presence of innovative portable and wearable monitoring devices designed for home use, and a growing awareness among patients.
"The electrodes segment to register the highest growth rate in the forecast period."
The electrodes segment is expected to register the highest growth rate in the forecast period. Technological progress has improved electrode-tissue interfaces, enabling the creation of cost-efficient, high-functioning electrodes within this market. Moreover, the integration of disposable electrodes has significantly propelled their acceptance and the expansion of this market segment.
"The Fixed devices accounted for the largest share of the modality segment of the brain monitoring market."
By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. Attributed to their established utilization in clinical environments like hospitals, specialized healthcare centers, and research institutions, these fixed devices are commonly regarded as the benchmark for comprehensive brain monitoring. Their reputation stems from their precision, dependability, and sophisticated features.
The traumatic brain injury segment accounted for the largest share of the brain monitoring market in 2022.
Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson's disease, epilepsy, Huntington's disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A key factor substantially boosting the market share of this segment is the notable rise in Traumatic Brain Injuries (TBIs) worldwide. This escalation in TBIs generates a considerable need for managing these cases, thereby requiring the widespread use of brain monitoring devices.
"North America to be the largest regional segment in the brain monitoring market during the forecast period."
Based on the region, the global brain monitoring market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the global brain monitoring market in 2022, while Asia Pacific is projected to be the fastest-growing region in the forecast period. The expansion of the market in Asia stems from several factors, including the expanding elderly population, access to affordable skilled labor, rising disposable incomes, an increased incidence of neurodegenerative disorders, and heightened governmental focus on healthcare reforms within the region.
Breakdown of primaries
The break of primary participants was as mentioned below:
By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
By Designation - C-level-35%, Director-level-25%, Others-40%
By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%
The brain monitoring market is dominated by a few globally established players such as Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Masimo Corporation (US), Unilabs Holdings AB (Sweden), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), Luciole Meidcal AG (Switzerland), Dragerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Integra LifeSciences Corporation (US), and Neurosoft (Russia).
Research Coverage:
The report segments the brain monitoring market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (devices and accessories), Procedure (Invasive, non-invasive), Modality (Fixed, Wearable, Portable), disease type (traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson's disease, epilepsy, Huntington's disease, and other diseases), end-user (into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end-users),
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the Brain Monitoring market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Brain Monitoring market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
.
Analysis of key drivers (increasing incidence and prevalence of neurological disorders, rising awareness of neurogenerative disorders, growing incidence of traumatic brain injuries), restraints (high cost of complex brain monitoring procedures and devices, unfavorable reimbursement policies), opportunities (increasing demand of non-invasive and minimally invasive devices), challenges (the shortage of trained professionals to effectively operate brain monitoring devices).
Market Penetration: Comprehensive information on product portfolios offered by the top players in the global brain monitoring market. The report analyzes this market by products, procedure, modality, medical condition, and end users.
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global brain monitoring market
Market Development: Comprehensive information on the lucrative emerging markets by products, procedure, modality, medical condition, and end users.
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global brain monitoring market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global brain monitoring market.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
1.4.2 REGIONS COVERED
FIGURE 2 REGIONAL SEGMENTATION
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 RESEARCH LIMITATIONS
1.6.1 SCOPE-RELATED LIMITATIONS
1.6.2 METHODOLOGY-RELATED LIMITATIONS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
TABLE 308 NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW
13.1.12 NEUROSOFT
TABLE 309 NEUROSOFT: COMPANY OVERVIEW
13.1.13 CGX
TABLE 310 CGX: COMPANY OVERVIEW
TABLE 311 CGX: OTHER DEVELOPMENTS, 2020-2024
13.1.14 NONIN
TABLE 312 NONIN: COMPANY OVERVIEW
13.1.15 RIMED
TABLE 313 RIMED: COMPANY OVERVIEW
TABLE 314 RIMED: DEALS, 2020-2024
13.1.16 EMOTIV
TABLE 315 EMOTIV: COMPANY OVERVIEW
13.1.17 DRAGERWERK AG & CO. KGAA
TABLE 316 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 52 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
13.1.18 MASIMO CORPORATION
TABLE 317 MASIMO CORPORATION: COMPANY OVERVIEW
FIGURE 53 MASIMO CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 318 MASIMO CORPORATION: DEALS, 2020-2024
13.1.19 LUCIOLE MEDICAL AG
TABLE 319 LUCIOLE MEDICAL AG: COMPANY OVERVIEW
TABLE 320 LUCIOLE MEDICAL AG: DEALS, 2020-2024
13.1.20 INTEGRA LIFESCIENCES
TABLE 321 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
FIGURE 54 INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022)
13.2 OTHER PLAYERS
13.2.1 INFRASCAN, INC.
13.2.2 NEUSOFT MEDICAL SYSTEMS CO., LTD.
13.2.3 NORAXON USA
13.2.4 STERNMED GMBH
13.2.5 CERIBELL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
